Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.

Eczemaletters header image 2

Tag Cloud

ige diaper elidel pimecrolimus flexural diaper dermatitis nipple immunosuppressant allergy test corticosteroid xerosis Pityrosporum ovale emollients dry dermatitis preservatives eczema dyshidrotic topical corticosteroids atopy corticosteroid cream skin folds corticosteroids nappy rash calcineurin allergic contact dermatitis burning sensation surfactants atopic eczema flare ups pompholyx irritant cancer atopic dermatitis blisters food allergies seasons moisturizers mometasone furoate perioral dermatitis keratosis pilaris tacrolimus seborrheic dermatitis itch skin flakes
Research
- Case of autoimmune progesterone dermatitis presenting as fixed drug eruption.
- FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics.
- Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.
- No association between nickel allergy and reporting cosmetic dermatitis from mascara or eye shadow: a cross-sectional general population study.
- Initial presentation of stasis dermatitis mimicking solitary lesions: A previously unrecognized clinical scenario.
- The effect of tobacco smoking and alcohol consumption on the prevalence of self-reported hand eczema: a cross-sectional population-based study.
- Granulomatous dermatitis with pseudoxanthoma elasticum-like changes: report of a case in a patient with cystic fibrosis.
- Successful retreatment with alitretinoin in relapsed chronic hand eczema patients.
- An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
- Increased expression of glucocorticoid receptor beta in lymphocytes of patients with severe atopic dermatitis unresponsive to topical corticosteroid.
News
- 5 Most Common Skin Disorders - FOXNews
- Vermont Soap Organics Launches New Liquid Sunshine Non Toxic Cleaning Kit - NPIcenter (press release)
- Risk Factors for Eczema Herpeticum - AAP Grand Rounds (registration)
- Information on genetic defect may enhance eczema treatments - AAP News (subscription)
- Welichem Begins Patient Enrollment for Phase IIb Trial of WBI-1001 Creams in ... - Canada NewsWire (press release)
- Your guide to good health this winter - India Today
- Lotion, tepid water, dermatologist can help with eczema - The Spokesman Review
- Provectus (PVCT) Announces Preliminary Phase 2 Data for PH-10 - TheOTCInvestor.com
- Provectus Reports Positive Preliminary Data for Dermatology Drug - OneMedPlace (blog)
- Dr Scott's Surgery - ChronicleLive

Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.

December 4th, 2009 · No Comments

Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.

Dermatol Online J. 2009;15(11):2

Authors: Benomar S, Boutayeb S, Afifi Y, Hamada S, Bouhllab J, Hassam B, Errihanni H

Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor that is responsible for several cutaneous side effects. We report a case of hand-foot syndrome associated with a papulo-pustular and seborrheic dermatitis-like eruption of the face in a 61-year-old patient treated with erlotinib for lung cancer.

PMID: 19951638 [PubMed - in process]

→ Discuss article in Forum Tags: Research

0 responses so far ↓

There are no comments yet...Kick things off by filling out the form below.

You must log in to post a comment.